Volume 143, Issue 4, Pages e3 (October 2012)

Slides:



Advertisements
Similar presentations
Volume 131, Issue 4, Pages (October 2006)
Advertisements

Volume 138, Issue 2, Pages e3 (February 2010)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 150, Issue 2, Pages e9 (February 2016)
Volume 133, Issue 6, Pages (December 2007)
Volume 141, Issue 6, Pages e7 (December 2011)
Volume 135, Issue 1, Pages (July 2008)
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 149, Issue 7, Pages e8 (December 2015)
Volume 135, Issue 4, Pages (October 2008)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 132, Issue 4, Pages (April 2007)
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Volume 129, Issue 1, Pages (July 2005)
Volume 138, Issue 4, Pages (April 2010)
Volume 138, Issue 3, Pages e4 (March 2010)
Volume 136, Issue 7, Pages e4 (June 2009)
Volume 131, Issue 4, Pages (October 2006)
Volume 128, Issue 5, Pages (May 2005)
Volume 133, Issue 6, Pages (December 2007)
Volume 123, Issue 4, Pages (October 2002)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 141, Issue 2, Pages e4 (August 2011)
Volume 150, Issue 2, Pages (February 2016)
Volume 25, Issue 4, Pages (April 2014)
Volume 127, Issue 2, Pages (August 2004)
Volume 149, Issue 7, Pages e8 (December 2015)
Molecular Imaging in Gastrointestinal Endoscopy
Volume 142, Issue 5, Pages e6 (May 2012)
Volume 128, Issue 4, Pages (April 2005)
Volume 137, Issue 3, Pages e3 (September 2009)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 142, Issue 2, Pages e2 (February 2012)
Galectin-1 suppresses experimental colitis in mice
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 132, Issue 3, Pages (March 2007)
Volume 145, Issue 3, Pages e3 (September 2013)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 139, Issue 1, Pages e6 (July 2010)
Volume 146, Issue 3, Pages (March 2014)
Volume 136, Issue 2, Pages (February 2009)
E. Cario, G. Gerken, D.K. Podolsky  Gastroenterology 
Volume 134, Issue 1, Pages (January 2008)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 139, Issue 6, Pages (December 2010)
Volume 139, Issue 6, Pages (December 2010)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
This Month in Gastroenterology
Volume 145, Issue 1, Pages e3 (July 2013)
Volume 146, Issue 1, Pages (January 2014)
Volume 134, Issue 7, Pages e3 (June 2008)
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Volume 119, Issue 4, Pages (October 2000)
Volume 136, Issue 2, Pages e2 (February 2009)
Volume 146, Issue 7, Pages e4 (June 2014)
Volume 13, Issue 9, Pages (December 2015)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Volume 135, Issue 2, Pages e2 (August 2008)
Heparin-Binding EGF-Like Growth Factor Increases Intestinal Microvascular Blood Flow in Necrotizing Enterocolitis  Xiaoyi Yu, Andrei Radulescu, Nicholas.
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 25, Issue 7, Pages (July 2017)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Volume 132, Issue 3, Pages (March 2007)
Volume 136, Issue 7, Pages (June 2009)
Presentation transcript:

Volume 143, Issue 4, Pages 1027-1036.e3 (October 2012) An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice  Long Binh Vong, Tsutomu Tomita, Toru Yoshitomi, Hirofumi Matsui, Yukio Nagasaki  Gastroenterology  Volume 143, Issue 4, Pages 1027-1036.e3 (October 2012) DOI: 10.1053/j.gastro.2012.06.043 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Schematic illustration of RNPO and nanotherapy for DSS-induced colitis in mice. (A) RNPO is prepared by self-assembly of a methoxy-poly(ethylene glycol)-b-poly(4-[2,2,6,6-tetramethylpiperidine-1-oxyl]oxymethylstyrene) block copolymer possessing nitroxide radical as a side chain of hydrophobic segment. (B) After oral administration, low-molecular-weight drugs such as TEMPOL are degraded and absorbed into the bloodstream in the stomach and small intestine before reaching the colon. In contrast, RNPO is stable and withstands the harsh conditions of the gastrointestinal tract (GIT) and reaches the colon to scavenge ROS, especially at sites of inflammation. Gastroenterology 2012 143, 1027-1036.e3DOI: (10.1053/j.gastro.2012.06.043) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Specific accumulation of RNPO in mice with colitis. (A) Localization of RNPO in the colon was determined with rhodamine-labeled RNPO. Mice were killed 4 hours after oral administration of 1 mL of rhodamine-labeled RNPO at a dose of 5 mg/mL (n = 3 mice per group), and colon sections were prepared. Localization of rhodamine-labeled RNPO in the colon was analyzed by fluorescent microscopy. Scale bars = 200 μm. (B) Accumulation of low-molecular-weight TEMPOL, RNPO, and polystyrene latex particles in the colon. After oral administration of low-molecular-weight TEMPOL, RNPO, and polystyrene latex particles with equivalent nitroxide radicals (1.33 mg; 7.5 μmol/L), the amount of nitroxide radicals was measured by ESR. Data are expressed as mean ± SEM. n = 3 mice per group. (C) Specific accumulation of RNPO in the inflamed colon. Colitis was induced in mice by supplementing the drinking water with DSS (3% wt/vol) for 5 days. The amount of nitroxide radicals in the normal colon and the inflamed colon was determined by measurement of ESR 4 hours after administration of RNPO. Data are expressed as mean ± SEM. n = 3 mice per group. Gastroenterology 2012 143, 1027-1036.e3DOI: (10.1053/j.gastro.2012.06.043) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 Biodistribution of RNPO in the gastrointestinal tract and bloodstream. (A) The biodistribution of RNPO was determined using 125I-labeled RNPO. The percentages of radioactivity in each organ and in the blood were determined by comparison to the initial total radioactivity. Data are expressed as mean ± SEM. n = 5 mice per group. (B) Absorption of low-molecular-weight TEMPOL and RNPO into the bloodstream of healthy mice (solid line) and mice with colitis (dashed line). After administration of low-molecular-weight TEMPOL and RNPO, the amount of nitroxide radicals in the plasma was determined by measurement of ESR. Data are expressed as mean ± SEM. n = 3 mice per group. (Inset) The ESR spectra of low-molecular-weight TEMPOL (grey spectrum) and RNPO (black spectrum) in the colon homogenate after 4 hours of oral administration. Gastroenterology 2012 143, 1027-1036.e3DOI: (10.1053/j.gastro.2012.06.043) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 Therapeutic effect of RNPO on DSS-induced colitis in mice. (A) Changes in DAI. DAI is the summation of the stool consistency index (0–3), fecal bleeding index (0–3), and weight loss index (0–4). Data are expressed as mean ± SEM, *P < .05, **P < .01, and ***P < .001 vs control group; ‡P < .05 and ¶P < .001 vs DSS groups, n = 6–7 mice per group, 2-way analysis of variance, followed by Bonferroni post hoc test. (B) Preservation of colon length. After 7 days of treatment, the colon was collected and measured. Data are expressed as mean ± SEM, **P < .01. n = 6–7 mice per group. (C) Protection of mucosal architecture. After 7 days of treatment, the colon was collected, and 7-μm–thick sections of distal colon were prepared. Sections of the distal colon were stained by H&E and assessed histologically. Scale bars, 200 μm. Gastroenterology 2012 143, 1027-1036.e3DOI: (10.1053/j.gastro.2012.06.043) Copyright © 2012 AGA Institute Terms and Conditions

Figure 5 Hematologic analyses in the peripheral blood and intravital observation of colon. (A–C) After 7 days of treatment, blood was collected by intracardiac puncture with a heparin-containing syringe, and hematologic analyses were performed using an automatic hematology analyzer (Celltac α, MEK-6358; Nihon Kohden Co, Tokyo, Japan). Blood samples were analyzed for (A) white blood cells, (B) red blood cells, and (C) hemoglobin. Data are expressed as mean ± SEM. *P < .05, **P < .01, ***P < .001. n = 6 mice per group. (D) The desquamation of impaired epithelial cells and cell death in colonic mucosa were determined by in vivo microscopic live imaging and propidium iodide staining. The bright field images were acquired 2 hours after removing remains in the colon. The cell death images were recorded immediately after staining of propidium iodide under an excitation wavelength of 488 nm and an emission wavelength of 515 nm. Gastroenterology 2012 143, 1027-1036.e3DOI: (10.1053/j.gastro.2012.06.043) Copyright © 2012 AGA Institute Terms and Conditions

Figure 6 RNPO reduced proinflammatory mediators and increased survival rate in mice with colitis. (A–C) After 7 days of treatment, colon homogenates were prepared, and MPO activity, superoxide, and IL-1β were measured. (A) MPO activity was determined by a colorimetric assay using o-dianisidine hydrochloride and H2O2 as substrates. (B) Measurement of IL-1β in colon homogenate was performed with an enzyme-linked immunosorbent assay kit for mice. Protein content in the colon homogenate was determined by a Micro BCA Protein Assay Kit. (C) Generation of superoxide in colon homogenates was measured by dihydroethidium fluorescence. The fluorescence intensity was measured with an excitation wavelength of 530 nm and an emission wavelength of 620 nm. Superoxide values were expressed as intensity per milligram of protein, and the superoxide value of the control group was standardized to 100%. Data are expressed as mean ± SEM. *P < .05, **P < .01, ***P < .001. n = 6 mice per group. (D) The survival rate of mice was determined after 15 days of 3% (wt/vol) DSS treatment. Starting on day 5, test drugs were orally administered daily until day 15. The number of surviving mice was counted until day 15. n = 6 mice per group. Gastroenterology 2012 143, 1027-1036.e3DOI: (10.1053/j.gastro.2012.06.043) Copyright © 2012 AGA Institute Terms and Conditions

Supplementary Figure 1 Oral administration of RNPO reduced DAI in mice with colitis. (A) Changes in percentage of initial body weight. (B) Changes in stool consistency index. (C) Changes in feces bleeding index. DAI is summation of stool consistency index (0–3), fecal bleeding index (0–3), and weight loss index (0–4). Data are expressed as mean ± SEM. *P < .05, **P < .01, and ***P < .001 vs control group; ‡P < .05, §P < .01, and ¶P < .001 vs DSS group. n = 6–7 per group. Gastroenterology 2012 143, 1027-1036.e3DOI: (10.1053/j.gastro.2012.06.043) Copyright © 2012 AGA Institute Terms and Conditions